Trevi Therapeutics, Inc. (TRVI)
NASDAQ: TRVI · Real-Time Price · USD
7.98
+0.02 (0.25%)
At close: Sep 17, 2025, 4:00 PM EDT
7.94
-0.04 (-0.50%)
Pre-market: Sep 18, 2025, 8:03 AM EDT
Trevi Therapeutics Market Cap
Trevi Therapeutics has a market cap or net worth of $971.78 million as of September 18, 2025. Its market cap has increased by 323.64% in one year.
Market Cap
971.78M
Enterprise Value
768.79M
1-Year Change
323.64%
Ranking
Category
Stock Price
$7.98
Market Cap Chart
Since May 7, 2019, Trevi Therapeutics's market cap has increased from $84.99M to $971.78M, an increase of 1,043.42%. That is a compound annual growth rate of 46.60%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 17, 2025 | 971.78M | 163.94% |
| Dec 31, 2024 | 368.19M | 330.28% |
| Dec 29, 2023 | 85.57M | -26.01% |
| Dec 30, 2022 | 115.65M | 472.04% |
| Dec 31, 2021 | 20.22M | -54.55% |
| Dec 31, 2020 | 44.48M | -33.49% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| May 7, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 686.51B |
| Johnson & Johnson | 424.98B |
| AbbVie | 382.04B |
| UnitedHealth Group | 307.73B |
| Novo Nordisk | 253.09B |
| AstraZeneca | 240.11B |
| Novartis AG | 237.94B |
| Abbott Laboratories | 231.06B |